Naticon Research Labs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-07-2024
- Paid Up Capital ₹ 0.24 M
as on 11-07-2024
- Company Age 23 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -21.11%
(FY 2020)
- Profit -75.00%
(FY 2020)
- Ebitda 51.64%
(FY 2020)
- Net Worth 0.74%
(FY 2020)
- Total Assets -6.28%
(FY 2020)
About Naticon Research Labs
The Corporate was formerly known as Naticon Research Lab Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.24 M, as per Ministry of Corporate Affairs (MCA) records.
Anoop Tiwari, Shibu Babu, and Shrikant Gupta serve as directors at the Company.
- CIN/LLPIN
U24239MH2001PTC131040
- Company No.
131040
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Naticon Research Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shibu Babu  | Director | 28-Feb-2001 | Current |
| Anoop Tiwari | Director | 28-Feb-2001 | Current |
| Shrikant Gupta | Director | 28-Feb-2001 | Current |
Financial Performance of Naticon Research Labs.
Naticon Research Labs Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 21.11% decrease. The company also saw a substantial fall in profitability, with a 75% decrease in profit. The company's net worth moved up by a moderate rise of 0.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Naticon Research Labs?
In 2019, Naticon Research Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Natalis Life Sciences Private LimitedActive 19 years 8 monthsAnoop Tiwari, Shibu Babu and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Naticon Research Labs?
Naticon Research Labs has a workforce of 64 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Naticon Research Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naticon Research Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
